Literature DB >> 6852190

Angiogenic factor in vitreous from diabetic retinopathy.

C R Hill, R D Kissun, J B Weiss, A Garner.   

Abstract

Vitreous from patients with proliferative diabetic retinopathy contains an angiogenic substance which stimulates the proliferation of blood vessels on the chick chorioallantoic membrane, whereas vitreous from non-diabetics who do not have a proliferative retinopathy does not.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6852190     DOI： 10.1007/bf01971107

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  9 in total

1.  Vitreous contraction in proliferative diabetic retinopathy.

Authors:  M D Davis
Journal:  Arch Ophthalmol       Date:  1965-12

2.  Studies on retinal neovascularization. Friedenwald Lecture.

Authors:  A Patz
Journal:  Invest Ophthalmol Vis Sci       Date:  1980-10       Impact factor: 4.799

3.  A low-molecular-weight angiogenic factor in cat retina.

Authors:  R D Kissun; C R Hill; A Garner; P Phillips; S Kumar; J B Weiss
Journal:  Br J Ophthalmol       Date:  1982-03       Impact factor: 4.638

Review 4.  Treatment of diabetic retinopathy.

Authors:  J C Liang; M F Goldberg
Journal:  Diabetes       Date:  1980-10       Impact factor: 9.461

5.  The effect of human intraocular fluid on vascular endothelial cell migration.

Authors:  B M Glaser; P A D'Amore; R G Michels
Journal:  Ophthalmology       Date:  1981-09       Impact factor: 12.079

6.  The demonstration of angiogenic activity from ocular tissues. Preliminary report.

Authors:  B M Glaser; P A D'Amore; R G Michels; S K Brunson; A H Fenselau; T Rice; A Patz
Journal:  Ophthalmology       Date:  1980-05       Impact factor: 12.079

7.  Experimental ocular angiogenesis.

Authors:  J L Federman; G C Brown; N T Felberg; S M Felton
Journal:  Am J Ophthalmol       Date:  1980-02       Impact factor: 5.258

8.  Angiogenic activity from bovine retina: partial purification and characterization.

Authors:  P A D'Amore; B M Glaser; S K Brunson; A H Fenselau
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

9.  An angiogenic factor isolated from tumours: a potent low-molecular-weight compound.

Authors:  J B Weiss; R A Brown; S Kumar; P Phillips
Journal:  Br J Cancer       Date:  1979-09       Impact factor: 7.640
  9 in total
  6 in total

1.  Microvascular complications and the diabetic pregnancy.

Authors:  Melton J Bond; Jason G Umans
Journal:  Curr Diab Rep       Date:  2006-08       Impact factor: 4.810

2.  Endothelial-cell-stimulating angiogenesis factor (ESAF) activates progelatinase A (72 kDa type IV collagenase), prostromelysin 1 and procollagenase and reactivates their complexes with tissue inhibitors of metalloproteinases: a role for ESAF in non-inflammatory angiogenesis.

Authors:  B McLaughlin; J B Weiss
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

Review 3.  Tumor-derived angiogenesis factors from rat Walker 256 carcinoma: an experimental investigation and review.

Authors:  B L Vallee; J F Riordan; R R Lobb; N Higachi; J W Fett; G Crossley; R Bühler; G Budzik; K Breddam; J L Bethune
Journal:  Experientia       Date:  1985-01-15

4.  Increased procollagenase activating angiogenic factor in the vitreous humour of oxygen treated kittens.

Authors:  C M Taylor; J B Weiss; B McLaughlin; R D Kissun; A Garner
Journal:  Br J Ophthalmol       Date:  1988-01       Impact factor: 4.638

Review 5.  A chronic grey matter penumbra, lateral microvascular intussusception and venous peduncular avulsion underlie diabetic vitreous haemorrhage.

Authors:  David McLeod
Journal:  Br J Ophthalmol       Date:  2007-05       Impact factor: 4.638

Review 6.  Angiogenesis-Inflammation Cross Talk in Diabetic Retinopathy: Novel Insights From the Chick Embryo Chorioallantoic Membrane/Human Vitreous Platform.

Authors:  Sara Rezzola; Alessandra Loda; Michela Corsini; Francesco Semeraro; Tiziana Annese; Marco Presta; Domenico Ribatti
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.